Cargando…
Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications
Despite advances in diagnosis and new treatments such as targeted therapies, breast cancer (BC) is still the most prevalent tumor in women worldwide and the leading cause of death. The principal obstacle for successful BC treatment is the acquired or de novo resistance of the tumors to the systemic...
Autores principales: | Campos-Parra, Alma D., Cuamani Mitznahuatl, Gerardo, Pedroza-Torres, Abraham, Vázquez Romo, Rafael, Porras Reyes, Fany Iris, López-Urrutia, Eduardo, Pérez-Plasencia, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486005/ https://www.ncbi.nlm.nih.gov/pubmed/28574440 http://dx.doi.org/10.3390/ijms18061182 |
Ejemplares similares
-
Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer
por: López-Urrutia, Eduardo, et al.
Publicado: (2019) -
miRNA profile obtained by next-generation sequencing in metastatic breast cancer patients is able to predict the response to systemic treatments
por: Martinez-Gutierrez, Antonio Daniel, et al.
Publicado: (2019) -
Alternative splicing regulation in tumor necrosis factor-mediated inflammation
por: López-Urrutia, Eduardo, et al.
Publicado: (2017) -
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
por: López-Urrutia, Eduardo, et al.
Publicado: (2021) -
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)